Company Overview and News
Parkway Minerals NL (ASX:PWN) has a portfolio of Australian projects aimed at supplying the fertiliser industry and is leveraged to the German potash assets of Davenport Resources (ASX:DAV).
Black Rock Mining (ASX:BKT) has decided to upgrade its pre-feasibility study to incorporate the recently delineated high grade portion of the Cascades deposit at the Mahenge graphite project located in Tanzania.
Highfield Resources Ltd (ASX:HFR) has signed a non-binding memorandum of understanding with Cargill, Inc. to assess the viability of salt sales into the US market from its Muga potash mine in northern Spain. High purity salt will be a primary by-product from the mine and is suitable for industrial applications. Cargill is the largest privately held corporation in the US with sales in FY15 of $120.4 billion.
Highfield Resources Ltd (ASX:HFR) has received a Buy rating from Foster Stockbroking, with a $2.30 share price target. Highfield shares last traded at $1.43. The following is an extract from the report. Event: June quarterly released. Commentary New Managing Director appointed as Muga approaches construction phase. Peter Albert appointed as Managing Director and CEO, effective from 1 September. Anthony Hall, HFR’s current Managing Director, will step down during a transitional period as Muga approaches the all - important construction phase, requiring a different managerial skill set.
Highfield Resources Ltd (ASX:HFR) has signed non-binding offtake agreements with fertiliser traders covering more than 100% of expected phase one production from its flagship Muga potash mine in northern Spain. The traders include three globally recognised fertiliser trading companies Keytrade AG, Ameropa AG and Trammo Inc. The offtake agreement will cover up to 600,000 metric tonnes of K60 Muriate of Potash (MOP) per annum produced from Muga.
A completed scoping study by Highfield Resources Ltd (ASX:HFR) for "downstream" options for enhancing profit margins at Muga Potash mine found that a Sulphate of Potash fertiliser (SOP) operation would materially enhance profit margins of the overall project. The approvals process is nearing completion for Highfield’s Muga Potash Mine in Spain, providing a window to evaluate downstream processing that would boost profit margins and diversify its product offering.
Highfield Resources Ltd (ASX:HFR) has appointed proven mine builder Peter Albert as the new chief executive officer of the company to lead the transition from potash developer to a producer at its Muga potash mine in northern Spain. The appointment will take effect from 1 September 2016. The current managing director, Anthony Hall, will not continue into the construction phase in his current role and elected to return to Australia.
Highfield Resources Ltd (ASX:HFR) is hopeful of soon receiving an environmental impact declaration (DIA) followed by a mining concession from the Spanish government to begin construction at its Muga Potash Project in northern Spain. The Spanish central government’s Department of Agriculture, Food and Environment in Madrid (MAGRAMA) is reviewing the environmental and social impact assessment of the project.
Spanish potash company Highfield Resources Ltd (ASX:HFR) has been featured in a Navarran newspaper with the development of its potash projects, covering 550km2, in the potash and halite producing Ebro Basin in the Sanguesa area, Navarre Province in northern Spain. "A mine with 40 years of life generates great employment prospects for the region of Sangüesa." The local Navarran Government is in favour of this project as it supports the economy, while the Muga project is still pending a few approvals from the Government.
11h - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...